Expectant management of clinically localized prostatic cancer Journal Article


Authors: Warner, J.; Whitmore, W. F. Jr
Article Title: Expectant management of clinically localized prostatic cancer
Abstract: Among approximately 4,000 prostatic cancer registrations 75 patients with clinical stage B histologically proved prostatic cancer receiving no therapy for at least 1 year after diagnosis were identified and managed expectantly. Of the patients 29 had stage B1, 37 stage B2 and 9 stage B3 lesions. Eight patients ultimately elected definitive radiation treatment. First evidence of tumor progression was local in more than 90% of the cases. Overall median intervals were 78 months to local progression, 186 months to metastasis, 108 months to initiation of any treatment and 156 months to death. The rate of tumor progression was often consistent with protracted survival. Prostatic cancer and co-morbidity were each significant forces of mortality.
Keywords: adult; cancer survival; treatment outcome; aged; aged, 80 and over; survival rate; retrospective studies; major clinical study; histopathology; cancer localization; cancer growth; treatment planning; conference paper; cancer radiotherapy; cancer staging; follow-up studies; neoplasm staging; metastasis; cohort studies; time factors; prostate cancer; prostatic neoplasms; cause of death; prostatectomy; biopsy, needle; disease progression; androgen antagonists; clinical protocols; brachytherapy; middle age; human; male; priority journal
Journal Title: Journal of Urology
Volume: 152
Issue: 5 Pt. 2
ISSN: 0022-5347
Publisher: Elsevier Science, Inc.  
Date Published: 1994-11-01
Start Page: 1761
End Page: 1765
Language: English
PUBMED: 7933234
PROVIDER: scopus
DOI: 10.1016/s0022-5347(17)32380-7
DOI/URL:
Notes: The issue number is mistakenly printed as issue "2 Part 2" on the original publication front matter -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Willet F. Whitmore Jr
    139 Whitmore